Wang Sheng, Wang Jian-Qing, Lv Xiong-Wen
School of Pharmacy, Anhui Medical University, Hefei 230032, China.
Institute for Liver Disease of Anhui Medical University, Anhui Medical University, Hefei 230032, China.
Biomark Med. 2017 May;11(6):491-501. doi: 10.2217/bmm-2017-0011. Epub 2017 Jun 9.
Liver disease is a primary cause of liver-related morbidity and mortality worldwide. Currently, histological examination is the gold standard for diagnosis and classification of liver disease; however, due to its several drawbacks, including the risk of complications and sampling variability, noninvasive diagnostic options are favorable. Exosomal miRNAs have recently been considered as an important source of medical biomarkers due to being widely distributed in body fluids. This review summarizes existing concepts related to the origin, mode of transportation and possible functions of exosomal miRNAs, and recent findings on the role of exosomal miRNAs in liver diseases and development of exosomal miRNA-based diagnostic biomarkers in the primary forms of liver diseases.
肝脏疾病是全球肝脏相关发病和死亡的主要原因。目前,组织学检查是肝脏疾病诊断和分类的金标准;然而,由于其存在包括并发症风险和取样变异性在内的若干缺点,非侵入性诊断方法更受青睐。外泌体微小RNA(miRNA)由于广泛分布于体液中,最近被认为是医学生物标志物的重要来源。本综述总结了与外泌体miRNA的起源、运输方式和可能功能相关的现有概念,以及外泌体miRNA在肝脏疾病中的作用和基于外泌体miRNA的原发性肝脏疾病诊断生物标志物的最新研究结果。